Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 3/20 | 0.43 |
| ▸ | F2 | P00734 | 2/20 | 0.43 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.43 |
| ▸ | PLAU | P00749 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.43 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.43 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.43 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.43 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.43 |
| ▸ | PTP4A3 | O75365 | 1/20 | 0.43 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.43 |
| ▸ | F10 | P00742 | 1/20 | 0.43 |
| ▸ | PLG | P00747 | 1/20 | 0.43 |
| ▸ | S100B | P04271 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6727999 | 1.00 | PRMT1 (0.43) | PRMT1F2ST14PLAUGAA | |
| SCHEMBL19342431 | 0.98 | ALDH1A1 (0.42) | PRMT1F2ST14PLAUGAA | |
| SCHEMBL25230809 | 0.92 | ALDH1A1 (0.43) | GAATMPRSS2HRH3PRSS1ALDH1A1 | |
| SCHEMBL38655982 | 0.90 | KCNA3 (0.48) | PRMT1F2ST14PLAUGAA | |
| SCHEMBL24962708 | 0.87 | PDE2A (0.42) | MAOAHRH3TDP1MAOB | |
| SCHEMBL30754664 | 0.87 | PDE2A (0.42) | MAOAHRH3TDP1MAOB | |
| SCHEMBL30456834 | 0.87 | PDE2A (0.42) | MAOAHRH3TDP1MAOB | |
| SCHEMBL24961877 | 0.87 | PDE2A (0.42) | MAOAHRH3TDP1MAOB | |
| SCHEMBL24961870 | 0.87 | PDE2A (0.42) | MAOAHRH3TDP1MAOB | |
| SCHEMBL30754666 | 0.87 | PDE2A (0.42) | MAOAHRH3TDP1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534670-B2 | Liquid crystal compounds | Rolic Technologies AG (CH) | 2026-01-27 | — | — | US | disclosed |
| US-20250066666-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2025-02-27 | — | — | US | disclosed |
| EP-4444822-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2024-10-16 | — | — | EP | disclosed |
| CN-118318024-A | Liquid crystal compound | 罗利克技术有限公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2023104545-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2023-06-15 | — | — | WO | disclosed |
| CN-111212878-B | Liquid crystal aligning agent, liquid crystal alignment film, method for producing same, and liquid crystal element | JSR株式会社 | 2022-06-14 | — | — | CN | disclosed |
| CN-111212878-A | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal element | JSR株式会社 | 2020-05-29 | — | — | CN | disclosed |
| US-9139774-B2 | Diacetylene derivative and liquid crystalline polymer having diacetylene structure | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2015-09-22 | — | — | US | disclosed |
| EP-1187802-B1 | LIQUID CRYSTAL COMPOUNDS | ROLIC AG (CH) | 2008-01-02 | — | — | EP | disclosed |
| US-20060166033-A1 | Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use | MERCK PATENT GMBH (DE) | 2006-07-27 | — | — | US | disclosed |
| CN-1228293-C | Reactive triphenyl diacetylene compound and liquid crystal polymer containing same | IND TECH RES INST (CN) | 2005-11-23 | — | — | CN | disclosed |
| CN-1413969-A | Reactive triphenyl diacetylene compound and liquid crystal polymer containing same | IND TECHNOLOGY INST (CN) | 2003-04-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534670-B2 | Liquid crystal compounds | SCO2, LBR, C1R | PRMT1 4357/4885F2 595/4885ST14 3500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.